The approval of Wegovy was a significant milestone in metabolic medicine
CJC-1295+ipamorelin may help support better sleep quality, which is crucial for recovery and overall health
While 503B facilities are required to follow current Good Manufacturing Practices (cGMP), the compounded drugs themselves are not FDA-approved. If semaglutide and tirzepatide are removed from the 503B bulks list, the availability of compounded GLP-1s would drop significantly, Michael Snyder, MD, FACS, FASMBS, DABOM, medical director of the Bariatric Surgery Center at Rose Medical Center, founder and director of the Denver Center for Bariatric Surgery Foundation, and in-house obesity specialist at FuturHealth, told MNT
For someone who is already feeling disconnected from their body or struggling with how it looks, using a medication that reduces hunger cues can create a slippery slope to intentional restriction, guilt, and shame around eating